Standout Papers

Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants 2020 2026 2022 2024414
  1. Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants (2020)
    M. Pamela Griffin, Yuan Yuan et al. New England Journal of Medicine

Immediate Impact

10 by Nobel laureates 24 from Science/Nature 64 standout
Sub-graph 1 of 22

Citing Papers

The therapeutic age of the neonatal Fc receptor
2023 Standout
Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants
2023 Standout

Works of John P. DeVincenzo being referenced

Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants
2020 Standout

Author Peers

Author Last Decade Papers Cites
John P. DeVincenzo 4664 1995 2140 135 6.5k
F. A. Waldvogel 1517 1786 567 111 7.5k
Richard D. Meyer 1751 1836 504 134 4.9k
John V. Williams 6987 3509 1935 228 8.8k
Hirokazu Kimura 1547 1804 614 241 4.3k
James H. Simon 1080 1120 303 63 3.4k
Deborah Greenspan 2624 2262 833 163 8.7k
Pentti Kuusela 929 1028 390 130 5.5k
Cavan Reilly 1257 1809 352 114 6.6k
Lauren O. Bakaletz 3384 675 1357 197 7.8k
Kristian Riesbeck 3096 945 794 267 8.1k

All Works

Loading papers...

Rankless by CCL
2026